Bone health

In other news: CGM product review; Skeletal age calculator; Cancer deaths in diabetes

CGM products to be reviewed by Medicare for cost-effectiveness The government is to review the value of Continuous Glucose Monitoring (CGM) devices subsidised on the NDSS with a cost effectiveness audit overseen by the Medicare Services Advisory Committee. The aim is to ensure that the NDSS’s CGM Initiative which began in April 2017 is clinically ...

Already a member?

Login to keep reading.

© 2021 the limbic